IN2014CH00872A - - Google Patents
Download PDFInfo
- Publication number
- IN2014CH00872A IN2014CH00872A IN872CH2014A IN2014CH00872A IN 2014CH00872 A IN2014CH00872 A IN 2014CH00872A IN 872CH2014 A IN872CH2014 A IN 872CH2014A IN 2014CH00872 A IN2014CH00872 A IN 2014CH00872A
- Authority
- IN
- India
- Prior art keywords
- preparation
- improved process
- ritonavir
- present disclosure
- disclosure provides
- Prior art date
Links
- 238000000034 method Methods 0.000 abstract 2
- NCDNCNXCDXHOMX-XGKFQTDJSA-N ritonavir Chemical compound N([C@@H](C(C)C)C(=O)N[C@H](C[C@H](O)[C@H](CC=1C=CC=CC=1)NC(=O)OCC=1SC=NC=1)CC=1C=CC=CC=1)C(=O)N(C)CC1=CSC(C(C)C)=N1 NCDNCNXCDXHOMX-XGKFQTDJSA-N 0.000 abstract 2
- NCDNCNXCDXHOMX-UHFFFAOYSA-N Ritonavir Natural products C=1C=CC=CC=1CC(NC(=O)OCC=1SC=NC=1)C(O)CC(CC=1C=CC=CC=1)NC(=O)C(C(C)C)NC(=O)N(C)CC1=CSC(C(C)C)=N1 NCDNCNXCDXHOMX-UHFFFAOYSA-N 0.000 abstract 1
- 229960000311 ritonavir Drugs 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PCT/IB2015/051223 WO2015125082A1 (en) | 2014-02-21 | 2015-02-18 | Improved process for the preparation of ritonavir |
IN872CH2014 IN2014CH00872A (enrdf_load_html_response) | 2014-02-21 | 2015-02-18 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IN872CH2014 IN2014CH00872A (enrdf_load_html_response) | 2014-02-21 | 2015-02-18 |
Publications (1)
Publication Number | Publication Date |
---|---|
IN2014CH00872A true IN2014CH00872A (enrdf_load_html_response) | 2015-08-28 |
Family
ID=52693001
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IN872CH2014 IN2014CH00872A (enrdf_load_html_response) | 2014-02-21 | 2015-02-18 |
Country Status (2)
Country | Link |
---|---|
IN (1) | IN2014CH00872A (enrdf_load_html_response) |
WO (1) | WO2015125082A1 (enrdf_load_html_response) |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5552558A (en) | 1989-05-23 | 1996-09-03 | Abbott Laboratories | Retroviral protease inhibiting compounds |
US5567823A (en) * | 1995-06-06 | 1996-10-22 | Abbott Laboratories | Process for the preparation of an HIV protease inhibiting compound |
US6037157A (en) | 1995-06-29 | 2000-03-14 | Abbott Laboratories | Method for improving pharmacokinetics |
US6894171B1 (en) | 1998-07-20 | 2005-05-17 | Abbott Laboratories | Polymorph of a pharmaceutical |
US7205413B2 (en) | 2002-05-03 | 2007-04-17 | Transform Pharmaceuticals, Inc. | Solvates and polymorphs of ritonavir and methods of making and using the same |
US20100099885A1 (en) * | 2006-10-03 | 2010-04-22 | Mukesh Kumar Sharma | Process for the preparation of form i and form ii of ritonavir |
-
2015
- 2015-02-18 WO PCT/IB2015/051223 patent/WO2015125082A1/en active Application Filing
- 2015-02-18 IN IN872CH2014 patent/IN2014CH00872A/en unknown
Also Published As
Publication number | Publication date |
---|---|
WO2015125082A1 (en) | 2015-08-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ZA202307128B (en) | Anti-cd38 antibodies for treatment of acute myeloid leukemia | |
PH12020550781A1 (en) | Anti-jagged1 antibodies and methods of use | |
PH12017500877A1 (en) | ANTI-CD79b ANTIBODIES AND METHODS OF USE | |
PH12017500322A1 (en) | Anti-her2 antibodies and immunoconjugates | |
GB2556286A (en) | Programmable voltage reference | |
PH12016501700A1 (en) | Combination therapies with anti-cd38 antibodies | |
PH12016501763A1 (en) | Multispecific antibodies | |
MA40579A (fr) | Anticorps anti-cll-1 et immunoconjugués | |
MY184870A (en) | Immunomodulators | |
EP4272738A3 (en) | Anti-cd38 antibodies for treatment of acute lymphoblastic leukemia | |
MX2016015162A (es) | Anticuerpos anti - gpc3 e inmunoconjugados. | |
EP3166931A4 (en) | An improved process for the preparation of enzalutamide | |
IN2013MU00848A (enrdf_load_html_response) | ||
MX2020007742A (es) | Procesos para preparar fluorocetolidos. | |
MX2016016233A (es) | Anticuerpos anti-lgr5 y sus usos. | |
MX2017001331A (es) | Composicion farmaceutica oral de isotretinoina. | |
IN2014CH00304A (enrdf_load_html_response) | ||
NZ721832A (en) | Solid forms of tenofovir | |
EA201692246A1 (ru) | Способ получения 2,6-диметилбензохинона | |
IN2014DE00883A (enrdf_load_html_response) | ||
IN2014CH00872A (enrdf_load_html_response) | ||
IN2014CH01391A (enrdf_load_html_response) | ||
UA103911U (ru) | Средство с вазодилатирующей активностью | |
IN2014MU01191A (enrdf_load_html_response) | ||
IN2014MU03184A (enrdf_load_html_response) |